Navigation Links
Arena Pharmaceuticals Provides Update on GPR119 Portfolio for Type 2 Diabetes
Date:11/4/2010

abolic diseases. Arena's most advanced drug candidate, lorcaserin, is intended for weight management. Arena's wholly owned subsidiary, Arena Pharmaceuticals GmbH, has granted Eisai Inc. exclusive rights to market and distribute lorcaserin in the United States, subject to FDA approval of the New Drug Application for lorcaserin.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company.

Forward-Looking StatementsCertain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the termination of Arena's collaboration with Ortho-McNeil-Janssen and related expectations and future activities; the therapeutic indication and use, safety, efficacy, tolerability, mechanism of action and potential of APD597 alone and in combination; the potential of GPR119; Arena's GPR119 patent portfolio and program and potential opportunities; the potential therapeutic indication and use, FDA approval and commercialization of lorcaserin; and Arena's focus, goals, strategy, research and development programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the risk that APD597 or GPR119 agonists as a class may not realize their potential or ever receive marketing approval; the risk that regulatory authorities may not find data and other information related to Arena's clinical trials and other studies sufficient for regulatory approval; the timing of regulatory review and approval is uncertain; Arena's response to the complete response letter for the lorcaserin NDA may not be submitted in a timely manner and/or the information
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
2. Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010
3. Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting
4. Arena Pharmaceuticals to Host Conference Call and Webcast Following Lorcaserin FDA Advisory Committee Meeting
5. Arena Pharmaceuticals Submits New Drug Application to FDA for Lorcaserin for Weight Management
6. Published Data Demonstrate Arena Pharmaceuticals Lorcaserin Has Low Abuse Potential
7. Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments
8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, November 10, 2009
9. Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
10. Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
11. Arena Pharmaceuticals to Host Conference Call and Webcast on Friday, September 18, 2009, to Discuss Results from the BLOSSOM Phase 3 Trial of Lorcaserin for Weight Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... Oct. 24, 2014 In conjunction with DURECT ... financial results press release, you are invited to listen ... over the internet on Monday, November 3, 2014 at ... A live audio webcast of the presentation will ... and clicking "Investor Relations."  If you are unable ...
(Date:10/25/2014)... CHAPEL HILL, N.C. , Oct. 24, 2014 ... virtual teams can provide a company access to ... about emerging markets, and round-the clock business hours ... requires overcoming difficult hurdles. According ... global team disappointments, such as seeing a project ...
(Date:10/22/2014)... Oct. 22, 2014  Quest Diagnostics (NYSE: ... services, today announced that its Board of Directors has ... director, effective December 1, 2014. Including Dr. Leiden, the ... the Chairman, President and CEO of Vertex Pharmaceuticals.   ... and commercial experience in the pharmaceutical and biotechnology industries ...
Breaking Medicine Technology:DURECT Corporation Invites You to Join its Third Quarter 2014 Earnings Conference Call 2Work Around the Clock: Successfully Building & Managing Global Virtual Teams 2Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 2Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 3
... 25, 2011 Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ... John H. Johnson as Chief Executive Officer, effective January 31, ... Savient,s board of directors. Mr. Johnson brings significant ... a Senior Vice President of Eli Lilly and Company and ...
... recently launched eCS Inpatient EHR V1.2 (eCS), the first ... medium hospitals. eCS,s uniqueness is the tight linkage of ... a single web-based software solution. The solution is offered ... simplified deployment. "eCS is an affordable solution ...
Cached Medicine Technology:Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer 2Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer 3Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer 4eCareSoft Launches Comprehensive EHR for Small & Medium Hospitals 2
(Date:10/25/2014)... 2014 Market Research Report ... 2009-2019 is a professional and in-depth market ... industry. The report firstly reviews the basic ... application and manufacturing technology. The report then ... Molecular Diagnostics listing their product specification, capacity, ...
(Date:10/25/2014)... 25, 2014 Limbkeepers® announced today that ... Innovations with Ed Begley Jr, airing 1st QTR 2015 ... In this episode, Innovations will focus on Limbkeepers® non ... fragile, thinning skin on arms, hands, and legs from ... these versatile products, which help reduce injuries, allow for ...
(Date:10/25/2014)... Oct. 23, 2014 (HealthDay News) -- A large influx ... Africa is to avoid tens of thousands of deaths ... University researchers predict. Using a specially designed ... of the outbreak in just one densely populated county ... capital city of Monrovia. The researchers said that ...
(Date:10/22/2014)... On Saturday, October 25, 2014, the Brownsville Community Health Center ... fair ¡Vive tu vida! Get Up! Get Moving!®. The event ... health and wellness for people of all ages and all ... public, will be held at Dean Porter Park, 501 E. ... , “¡Vive tu Vida! Get Up! Get Moving!® helps ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, ... Ebola cases in Dallas. But, mental health specialists say overblown ... President Barack Obama on Friday appointed an Ebola "czar" to ... two Dallas nurses who cared for a Liberian man who ... But the U.S. cases are miniscule in the context ...
Breaking Medicine News(10 mins):Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 3Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 4Health News:Upcoming Episode of Innovations with Ed Begley, Jr. to Feature Limbkeepers® 2Health News:Experts Predict 'Catastrophic' Ebola Epidemic in West Africa if Aid Delayed 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 3
... comparison study finds chlorthalidone most likely to prevent ... News) -- Tried-and-true diuretics maintain their status as ... women with high blood pressure, new research concludes. ... treatments -- a calcium channel blocker, an ACE ...
... , Government Also Files Suit Against New York Hospital ... WASHINGTON, Nov. 18 The United States has entered into ... motion to intervene in a lawsuit against a New York ... Department announced today. , The United States settled ...
... Sinai School of Medicine set out to address a ... do dietary restrictionand the reverse, overconsumptionproduce protective effects against ... two-part study led by Charles Mobbs, PhD, Professor of ... Sinai School of Medicine, published in the November 17 ...
... ... and spa therapy for 30 years, has received the distinguished School of Excellence Award ... only ACCSC-accredited school in Massachusetts to receive this 2008-2009 Award. , ... Woburn, MA, November 18, 2009-- ...
... ... The Adaptive Business Leaders (ABL) Organization is asking for nominations for ... 12th Annual Innovations in Healthcare(SM) Awards Event, on April 28, 2010, in ... their value-driven approaches to solving some of the toughest problems facing healthcare ...
... MINEOLA, N.Y., Nov. 18 The United States Preventive ... a woman should be getting a mammography. The Maurer ... an official statement regarding her research and beliefs on ... Yesterday, The United States Preventive Services Task Force (USPSTF) ...
Cached Medicine News:Health News:Diuretics Still Best Treatment for High Blood Pressure 2Health News:New Jersey Hospital to Pay $3 Million to Resolve Allegations of Medicare Fraud 2Health News:Scientists find molecular trigger that helps prevent aging and disease 2Health News:Scientists find molecular trigger that helps prevent aging and disease 3Health News:ACCSC Grants Catherine Hinds Institute of Esthetics a Distinguished School of Excellence Award Award Recognizes High-Level Achievements of Students 2Health News:ACCSC Grants Catherine Hinds Institute of Esthetics a Distinguished School of Excellence Award Award Recognizes High-Level Achievements of Students 3Health News:Nominate Your Favorite Innovative Healthcare Company for the 2010 ABBY Awards 2Health News:Nominate Your Favorite Innovative Healthcare Company for the 2010 ABBY Awards 3Health News:Nominate Your Favorite Innovative Healthcare Company for the 2010 ABBY Awards 4Health News:Maurer Foundation for Breast Health Education Statement on USPSTF Guidelines for Mammography 2
... The National Laboratory Training Network (NLTN) ... Association of Public Health Laboratories (APHL) and ... (CDC). NLTN provides cost-effective training in a ... resources, including a FREE Lending Library. Log ...
... The AAFP-PT Laboratory Proficiency Testing and Quality ... are designed to assist POLs, clinics and ... designed to assure accuracy of patient lab ... requirements. Participation provides the opportunity to earn ...
An indirect immunofluorescence (IFA) antibody test for the detection and semiquantitation of anti-glomerular basement membrane (GBM) antibodies in human serum. Slide Detail: 6-well Monkey Kidney Subs...
An enzyme linked immunosorbant assay (ELISA) for the detection and quantitation of Rheumatoid Factor (RF) of IgM isotype in human serum....
Medicine Products: